139 related articles for article (PubMed ID: 31801785)
1. Candidal perforation of the hard palate in an HIV-infected child.
Bhattarai D; Modak A; Suri D
BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31801785
[No Abstract] [Full Text] [Related]
2. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
[TBL] [Abstract][Full Text] [Related]
3. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
4. Palate ulcer due to mucormycosis.
Kyrmizakis DE; Doxas PG; Hajiioannou JK; Papadakis CE
J Laryngol Otol; 2002 Feb; 116(2):146-7. PubMed ID: 11827594
[TBL] [Abstract][Full Text] [Related]
5. Fluconazole-resistant pseudomembranous oral candidiasis.
Shetty K
Ann Pharmacother; 2006 May; 40(5):993. PubMed ID: 16638917
[No Abstract] [Full Text] [Related]
6. Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis.
Chavanet PY; Garry I; Charlier N; Caillot D; Kisterman JP; D'Athis M; Portier H
BMJ; 1992 Oct; 305(6859):921-5. PubMed ID: 1458072
[TBL] [Abstract][Full Text] [Related]
7. Oral candidiasis caused by Kodamaea ohmeri in a HIV patient in Chennai, India.
Menon T; Herrera M; Periasamy S; Palanivelu V; Sikhamani R; Wickes B
Mycoses; 2010 Sep; 53(5):458-9. PubMed ID: 19531098
[TBL] [Abstract][Full Text] [Related]
8. The treatment of oropharyngeal candidiasis in HIV-infected patients with oral amphotericin B suspension.
Hood S; Evans J; Bond J; Wilkins E; Denning D
AIDS Patient Care STDS; 1998 Aug; 12(8):625-7. PubMed ID: 15468434
[TBL] [Abstract][Full Text] [Related]
9. Atypical clinical manifestation of mucoepidermoid carcinoma in the palate.
Munhoz Ede A; Cardoso CL; Tjioe KC; Sant'ana E; Consolaro A; Damante JH; Rurira-Bullen IR
Gen Dent; 2009; 57(6):e51-3. PubMed ID: 21467005
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
[TBL] [Abstract][Full Text] [Related]
11. [Oral amphotericin B inefficacy in the treatment of fluconazole++ resistant oropharyngeal candidiasis in HIV-positive patients].
Laguna F; Valencia E; Polo R; Moreno V; González-Lahoz JM
Rev Clin Esp; 1996 Dec; 196(12):878-9. PubMed ID: 9132869
[No Abstract] [Full Text] [Related]
12. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
[TBL] [Abstract][Full Text] [Related]
13. [Factors related to oral candidiasis in HIV children and adolescents, species characterization and antifungal susceptibility].
Castillo-Martínez NA; Mouriño-Pérez RR; Cornejo-Bravo JM; Gaitán-Cepeda LA
Rev Chilena Infectol; 2018 Aug; 35(4):377-385. PubMed ID: 30534924
[TBL] [Abstract][Full Text] [Related]
14. Oral candidiasis in HIV-infected patients.
Brawner DL; Hovan AJ
Curr Top Med Mycol; 1995; 6():113-25. PubMed ID: 8724244
[No Abstract] [Full Text] [Related]
15. Oral mucosal fungal infections.
Samaranayake LP; Keung Leung W; Jin L
Periodontol 2000; 2009 Feb; 49():39-59. PubMed ID: 19152525
[No Abstract] [Full Text] [Related]
16. Oral candidiasis of HIV-infected children undergoing sequential HIV therapies.
Melo NR; Taguchi H; Culhari VP; Kamei K; Mikami Y; Smith SN; Vilela MS
Med Mycol; 2009 Mar; 47(2):149-56. PubMed ID: 18651304
[TBL] [Abstract][Full Text] [Related]
17. Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Ustianowski AP; Leake H; Evans S
Int J STD AIDS; 1997 Sep; 8(9):592-4. PubMed ID: 9292351
[No Abstract] [Full Text] [Related]
18. Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics.
Schmidt-Westhausen AM; Bendick C; Reichart PA; Samaranayake LP
Mycoses; 2004 Oct; 47(9-10):435-41. PubMed ID: 15504130
[TBL] [Abstract][Full Text] [Related]
19. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Anil S; Ellepola AN; Samaranayake LP
J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
[TBL] [Abstract][Full Text] [Related]
20. [Sensitivity of Candida strains to polyenic antibiotics in the treatment of oral candidiasis].
Boĭko GI; Sosnin GP; Adarchenko AA; Moroz GS
Antibiotiki; 1984 Nov; 29(11):869-72. PubMed ID: 6395795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
